Drug & medication recalls Moderate risk

Triamterene and Hydrochlorothiazide Capsules recalled over manufacturing violations

Recall date
January 26, 2022
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
CARDINAL HEALTHCARE recalls Triamterene and Hydrochlorothiazide Capsules, USP, 37.5 mg/25 mg, 100 capsules per bottle, Rx Only, Distributed by: Lan…
Recall number
D-0199-2024
FDA classification
Class II
Brand / firm
CARDINAL HEALTHCARE
Sold / distributed
Nationwide USA

Why it was recalled

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Triamterene and Hydrochlorothiazide Capsules, USP, 37.5 mg/25 mg, 100 capsules per bottle, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19136. NDC 0527-1632-01

Get recall alerts

Free email alert whenever CARDINAL HEALTHCARE has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: CARDINAL HEALTHCARE